Products
16723 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nike Constant Leverage with ISIN code: CH1345999507 | Nike | Constant Leverage | Short | ― | 75.581 | 18.05 | 0.220 | 18.27 | 1 | -0.22 % | -3.37 % | 107.23 % | 18 Apr. 2024 | |
Nokia Constant Leverage with ISIN code: CH1235293177 | Nokia | Constant Leverage | Long | ― | 3.623 | 0.24 | 0.010 | 0.25 | 1 | -4.00 % | 9.09 % | -17.24 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 3.623 | 0.83 | 0.010 | 0.84 | 1 | -1.19 % | 6.41 % | -8.79 % | 6 May. 2022 | |
Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 3.623 | 6.53 | 0.030 | 6.56 | 1 | -1.21 % | -9.05 % | -0.61 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1345998707 | Nokia | Constant Leverage | Short | ― | 3.623 | 2.83 | 0.020 | 2.85 | 1 | -1.74 % | -14.24 % | -3.74 % | 18 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746238 | Novartis | Constant Leverage | Long | ― | 97.415 | 13.6 | 0.050 | 13.65 | 1 | -0.37 % | 5.02 % | 10.12 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746246 | Novartis | Constant Leverage | Long | ― | 97.415 | 15.45 | 0.100 | 15.55 | 1 | -0.64 % | 7.29 % | 14.87 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 97.415 | 12.45 | 0.050 | 12.5 | 1 | 0.89 % | 5.06 % | 10.47 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 97.415 | 9.65 | 0.100 | 9.75 | 1 | 2.12 % | 12.34 % | 23.09 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1346746253 | Novartis | Constant Leverage | Long | ― | 97.415 | 17.3 | 0.150 | 17.45 | 1 | -0.86 % | 9.15 % | 18.49 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 97.415 | 12.35 | 0.070 | 12.42 | 1 | 1.31 % | 7.58 % | 15.10 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 97.415 | 11.36 | 0.090 | 11.45 | 1 | 1.79 % | 10.08 % | 19.33 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 97.415 | 3 | 0.020 | 3.02 | 1 | -0.33 % | -7.41 % | -18.48 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 97.415 | 4.86 | 0.020 | 4.88 | 1 | -0.21 % | -4.89 % | -12.27 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 97.415 | 1.72 | 0.010 | 1.73 | 1 | 0.58 % | -8.99 % | -23.89 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1346746220 | Novartis | Constant Leverage | Short | ― | 97.415 | 6.61 | 0.030 | 6.64 | 1 | -0.45 % | -6.11 % | -13.48 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746212 | Novartis | Constant Leverage | Short | ― | 97.415 | 5.24 | 0.030 | 5.27 | 1 | -0.38 % | -9.03 % | -20.00 % | 24 Apr. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 974.917 | 30.02 | 0.120 | 30.14 | 1 | 1.56 % | -11.29 % | 10.17 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587347 | Novo Nordisk | Constant Leverage | Long | ― | 974.917 | 34.24 | 0.200 | 34.44 | 1 | 2.33 % | -17.39 % | 12.08 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 974.917 | 10.39 | 0.300 | 10.69 | 1 | 1.17 % | -37.48 % | 4.63 % | 23 Feb. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.